Market entry strategies for the Gulf Cooperation Council tend to be built on a common misunderstanding: that the formal policy environment is the environment. In reality, the formal policy environment describes the rules. It says very little about how those rules work in practice, who makes decisions, and what actually determines whether an international player gets traction or spends two years trying to understand why their playbook is not working.
A global management consulting firm learned this distinction clearly when it engaged Nextyn to support a market entry mandate in Saudi Arabia and the UAE.
The client was an international healthcare business considering expansion into the GCC. Saudi Arabia and the UAE were the two markets under evaluation. The consulting team had done its homework on the secondary research side: Vision 2030 documents, Ministry of Health guidelines, regulatory frameworks, published market assessments from healthcare advisory firms. The structural picture was clear.
What remained unclear was the practitioner reality underneath it. How were procurement decisions actually being made in Saudi Arabia's evolving public-private healthcare structure? What did the real barriers to entry look like for international operators in the UAE, as distinct from the barriers described in the policy documents? And were the opportunity areas that published research was pointing to genuinely accessible, or were they accessible on paper while the actual competitive and relationship dynamics made them significantly harder to enter in practice?
The consulting team had two weeks to move from secondary research to practitioner-validated intelligence. They needed people who were inside the market, not people who studied it from a distance.
Nextyn was engaged to source GCC healthcare practitioners across the range of perspectives the consulting team needed. Several of the most relevant practitioners on the Saudi side were more accessible in Arabic than in English, and Nextyn's regional team managed the sourcing and facilitation accordingly.
Over ten days, conversations were facilitated with six practitioners. In Saudi Arabia: two former senior officials from the Ministry of Health with direct involvement in designing the public-private partnership frameworks under Vision 2030; and one healthcare operator who had recently completed the process of establishing a private facility under the updated licensing framework. In the UAE: a former senior executive from a major hospital group with experience navigating both the Dubai Health Authority and the Abu Dhabi Department of Health; and two healthcare investment advisors with active GCC transaction mandates who could speak to how investors were actually thinking about market entry risk in both emirates.
The Saudi Arabia findings restructured the team's thinking around what the actual constraint was. Both former Ministry officials described the Vision 2030 healthcare transformation as creating genuine opportunity, particularly in speciality care segments where Saudi Arabia was actively trying to develop domestic capacity. But both were equally clear that the procurement and partnership pathway was relationship-dependent in a way the policy documents had not captured. International operators who had invested in building working relationships with the relevant ministry departments and regional health clusters were moving measurably faster than those approaching the market through formal tender processes alone. The licensing framework mattered, but it was not the bottleneck. The relationship layer beneath it was.
On the UAE, the picture that came back was more immediately actionable. The former hospital group executive described a clear bifurcation between Dubai and Abu Dhabi that went well beyond regulatory differences. Dubai's market was more commercially competitive, more open to international operators with strong brand positioning, and more responsive to direct market approaches. Abu Dhabi's market was more government-linked, and a larger proportion of the high-value patient volume flowed through entities where institutional relationships were the primary access point. An operator that understood and succeeded in one emirate could not simply assume the same approach would transfer to the other.
Two aspects of the market entry strategy were restructured in response to the research findings. The Saudi Arabia recommendation moved away from a licensing and tender pathway approach toward one that made relationship development with the relevant Ministry departments a prerequisite step, before any formal commercial engagement. The partnership structures the team recommended were ones the practitioners had described as workable in practice, not ones the team had inferred from published policy.
The UAE strategy was differentiated by emirate from the outset, which would not have happened on the basis of secondary research alone. The client's decision about which emirate to enter first was reframed as a substantive strategic choice with meaningfully different implications, not a logistical sequencing question.
The GCC healthcare sector is one of the most significant expansion destinations for international operators, and one of the most poorly understood from the outside. The formal policy environment tells you what the government wants to achieve. It rarely tells you how decisions are actually made, what relationships matter, or where the real constraints on market access sit. That knowledge exists inside the market. The only way to access it is through practitioners who are navigating it every day.
